Molecular Determinants of Spinal Cord Injury Rehabilitation
proTmedula
proTmedula- Temporal Profile of Potential Molecular Determinants of Spinal Cord Injury Rehabilitation and Regeneration
2 other identifiers
observational
106
1 country
1
Brief Summary
This study main aim is to identify molecular determinants of better recovery following spinal cord injury (SCI), as biomarkers of neurological and/or functional improvement and a proxy for neuroregeneration. For that, omics analyses of several biological samples will be performed, to comprehensively portray the molecular and cellular profiles of the patients with SCI at key time points of the pathology: pre-rehabilitation, post-rehabilitation and one-year post-injury. The main question it aims to answer is: 'Are there specific molecules (and related biological pathways) that impact the functional recovery of spinal cord injury patients during the subacute phase, in a way that future targeted pharmacological or genetic interventions may improve SCI outcomes?'.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 16, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 16, 2023
CompletedFirst Submitted
Initial submission to the registry
January 17, 2026
CompletedFirst Posted
Study publicly available on registry
February 3, 2026
CompletedFebruary 3, 2026
January 1, 2026
2.5 years
January 17, 2026
January 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Molecular/cellular candidate biomarkers with a strong association to functional independence
Association between functional independence, assessed by the Spinal Cord Independence Measure, 4th version (SCIM IV), and by the Functional Independence Measure (FIM), with levels of specific molecular or cellular candidate biomarkers. Association studies will consider functional independence measures (at admission, their variation, and/or at discharge) and specific molecular or cellular candidate biomarkers, such as protein or bacterial levels (at admission, their variation, and/or at discharge).
From admission into the rehabilitation hospital (~2 months post-injury) until discharge (~4 months post-injury)
Molecular/cellular candidate biomarkers with a strong association to neuromotor impairment
Association between total motor scores, assessed by the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI), with levels of specific molecular or cellular candidate biomarkers. Association studies will consider ISNCSCI motor scores (at admission, their variation, and/or at discharge) and specific molecular or cellular candidate biomarkers, such as protein or bacterial levels (at admission, their variation, and/or at discharge).
From admission into the rehabilitation hospital (~2 months post-injury) until discharge (~4 months post-injury)
Secondary Outcomes (2)
Molecular/cellular candidate biomarkers identified in the primary outcome measures with a strong association to neurological impairment
From admission into the rehabilitation hospital (~2 months post-injury), across discharge (~4 months post-injury), and until follow-up (1-year post-injury)
Longitudinal profiles of key molecules (and bacteria) across post-intensive inpatient rehabilitation, and a period post-discharge (subacute and chronic phases)
From admission into the rehabilitation hospital (~2 months post-injury), across discharge (~4 months post-injury), and until follow-up (1-year post-injury)
Study Arms (2)
SCI cohort
Spinal cord injury patients admitted for hospitalization at Centro de Reabilitação do Norte, Unidade Local de Saúde de Gaia e Espinho, E.P.E. categorized into two subgroups: with A or B (motor complete injuries) classification, or with C or D (motor incomplete) classification in The American Spinal Injury Association (ASIA) Impairment Scale (AIS).
Able-bodied controls
Age, sex and body mass index-matched control group of participants recruited among able-bodied personnel from Centro de Reabilitação do Norte, Unidade Local de Saúde de Gaia e Espinho, E.P.E. or their relatives, without any known CNS disease.
Eligibility Criteria
Patients admitted to the North Rehabilitation Center ("Centro de Reabilitação do Norte, CRN-ULSGE") between 1st of May 2021 and 16th of October 2023, following a traumatic spinal cord injury.
You may qualify if:
- Clinically diagnosed with traumatic spinal cord injury
- Adults (≥18 years).
- Injury occurred less than 6 months ago (subacute phase).
- Classification A-D in The American Spinal Injury Association (ASIA) Impairment Scale (AIS).
- Any neurological level of injury.
You may not qualify if:
- Use of probiotics one-month prior admission.
- Use of immunomodulatory drugs one-month prior admission.
- Major gastrointestinal surgery in the last five years.
- Active gastrointestinal diseases.
- Other CNS diseases (besides SCI).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Department of Medical Sciences, University of Aveirocollaborator
- Centro de Reabilitacao do Nortecollaborator
- Centro Academico Clínico Egas Moniz Health Alliancecollaborator
- Aveiro Institute of Biomedicine (iBiMED)collaborator
- Unidade Local de Saude de Gaia e Espinho EPEcollaborator
- Prof. Sandra Vieiralead
Study Sites (1)
Centro de Reabilitação do Norte (CRN) / Unidade Local de Saúde Gaia e Espinho, E.P.E. (ULSGE), Vila Nova de Gaia,, Portugal
Vila Nova de Gaia, 4405-565 Vila Nova de Gaia, Portugal
Biospecimen
Blood, urine and fecal samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sandra I. Vieira, Prof. Dr.
Institute of Biomedicine, Department of Medical Sciences, University of Aveiro (iBiMED-UA)
- STUDY DIRECTOR
Maria Ribeiro da Cunha, MD
Centro de Reabilitação do Norte (CRN)/Unidade Local de Saúde de Gaia e Espinho, E.P.E. (ULSGE)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prof. Sandra I. Vieira
Study Record Dates
First Submitted
January 17, 2026
First Posted
February 3, 2026
Study Start
May 1, 2021
Primary Completion
October 16, 2023
Study Completion
October 16, 2023
Last Updated
February 3, 2026
Record last verified: 2026-01